US EditionNew Recall of Injected Penicillin May Put Gains Against Syphilis in Peril
UNITED STATES, JUL 16 – Pfizer is rationing Bicillin L-A after recalling contaminated lots, risking reversal of progress against a syphilis surge that increased tenfold since 2012, CDC data shows.
- In 2023, Pfizer recalled certain lots of Bicillin L-A due to contamination with floating particles, causing a shortage of this key syphilis treatment in the United States.
- The shortage occurred following reductions in funding for both national and local STD initiatives and complications related to stoppers from an outside supplier, which Pfizer is currently addressing through corrective measures.
- Bicillin L-A is the recommended long-acting penicillin injection for treating syphilis during pregnancy, while reported cases of congenital syphilis in the United States have risen sharply from 335 in 2012 to over 3,800 in 2023.
- Dr. Jeffrey Klausner warned this crisis "is a complete kick in the teeth" threatening syphilis control, while a CDC official expressed concern that funding cuts will cause drops in syphilis testing.
- Pfizer plans to ration supplies until recovery and the National Coalition of STD Directors is gathering data to assess the recall's impact amid ongoing efforts to import equivalent antibiotics.
27 Articles
27 Articles
A new recall of injected penicillin may put gains against syphilis in peril
(CNN) — Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during pregnancy.
A new recall of injected penicillin may put gains against syphilis in peril | News Channel 3-12
By Brenda Goodman, CNN (CNN) — Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during pregnancy. The news – the latest twist in a drug shortage that began in 2023 – follows a July 10 recall of certain lots of Bicillin L-A that were found to be contaminated with floating particles. Pfizer says it has not rec…
Pfizer penicillin recall imperils syphilis treatment supply, particularly for pregnant women
A recent drug recall of Pfizer’s penicillin product has put the immediate supply of a key syphilis treatment at risk, according to the company and a coalition of public health officials addressing sexually transmitted diseases ...
Penicillin recall puts recent gains against syphilis at risk
CNN- A new recall of injected penicillin may put recent gains against syphilis in pregnant women in jeopardy. Penicillin recall puts gains against syphilis at risk. Drugmaker Pfizer is warning doctors that it expects to run low on supplies of ‘Bicillin LA.’ That is the preferred antibiotic option for treating syphilis during pregnancy. Without treatment, syphilis during pregnancy can cause miscarriages and stillbirths. Pfizer’s warning follo…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
